Asian Paints:2,637.90-30.96 (-1.16%)
Cipla:1,410.60+17.55 (+1.26%)
Eicher Motors:7,628.00-93.43 (-1.21%)
Nestle India:1,443.50-4.34 (-0.30%)
Grasim Inds:3,089.40-23.66 (-0.76%)
Hindalco Inds.:942.80-12.81 (-1.34%)
Hind. Unilever:2,145.00-16.86 (-0.78%)
ITC:283.45+2.14 (+0.76%)
Trent:2,890.50+15.81 (+0.55%)
Larsen & Toubro:3,785.60-6.83 (-0.18%)
M & M:3,161.40-68.14 (-2.11%)
Reliance Industries:1,278.00+5.85 (+0.46%)
Tata Consumer:1,088.00-19.72 (-1.78%)
Tata Motors PVeh:323.80-0.49 (-0.15%)
Tata Steel:182.67-1.57 (-0.85%)
Wipro:177.12+2.31 (+1.32%)
Apollo Hospitals:8,805.50-56.72 (-0.64%)
Dr Reddy's Labs:1,151.70-14.58 (-1.25%)
Titan Company:4,677.00-20.20 (-0.43%)
SBI:1,015.00+2.43 (+0.24%)
Shriram Finance:1,005.10-20.72 (-2.02%)
Bharat Electron:405.00-0.36 (-0.09%)
Kotak Mah. Bank:384.75+1.42 (+0.37%)
Infosys:1,040.90-6.49 (-0.62%)
Bajaj Finance:1,012.80-27.04 (-2.60%)
Adani Enterp.:3,026.40+16.25 (+0.54%)
Sun Pharma.Inds.:1,941.10-12.90 (-0.66%)
JSW Steel:1,240.80-5.98 (-0.48%)
HDFC Bank:742.80-4.48 (-0.60%)
TCS:2,254.30+11.44 (+0.51%)
ICICI Bank:1,432.90-1.72 (-0.12%)
Power Grid Corpn:288.20-1.59 (-0.55%)
Maruti Suzuki:13,442.00+38.87 (+0.29%)
Axis Bank:1,227.30+4.28 (+0.35%)
HCL Technologies:1,271.00+26.26 (+2.11%)
O N G C:248.76-3.61 (-1.43%)
NTPC:347.20-1.39 (-0.40%)
Coal India:427.40+0.34 (+0.08%)
Bharti Airtel:1,898.20-32.83 (-1.70%)
Tech Mahindra:1,559.50+3.73 (+0.24%)
Jio Financial:234.71+1.54 (+0.66%)
Adani Ports:1,768.30-10.14 (-0.57%)
HDFC Life Insur.:555.05+4.08 (+0.74%)
SBI Life Insuran:1,858.60+5.19 (+0.28%)
Max Healthcare:1,080.40-3.79 (-0.35%)
UltraTech Cem.:11,846.00-61.92 (-0.52%)
Bajaj Auto:11,130.00-153.45 (-1.36%)
Bajaj Finserv:1,876.70-12.66 (-0.67%)
Interglobe Aviat:4,985.00-38.68 (-0.77%)
Eternal:280.00-7.09 (-2.47%)
Asian Paints:2,637.90-30.96 (-1.16%)
Cipla:1,410.60+17.55 (+1.26%)
Eicher Motors:7,628.00-93.43 (-1.21%)
Nestle India:1,443.50-4.34 (-0.30%)
Grasim Inds:3,089.40-23.66 (-0.76%)
Hindalco Inds.:942.80-12.81 (-1.34%)
Hind. Unilever:2,145.00-16.86 (-0.78%)
ITC:283.45+2.14 (+0.76%)
Trent:2,890.50+15.81 (+0.55%)
Larsen & Toubro:3,785.60-6.83 (-0.18%)
M & M:3,161.40-68.14 (-2.11%)
Reliance Industries:1,278.00+5.85 (+0.46%)
Tata Consumer:1,088.00-19.72 (-1.78%)
Tata Motors PVeh:323.80-0.49 (-0.15%)
Tata Steel:182.67-1.57 (-0.85%)
Wipro:177.12+2.31 (+1.32%)
Apollo Hospitals:8,805.50-56.72 (-0.64%)
Dr Reddy's Labs:1,151.70-14.58 (-1.25%)
Titan Company:4,677.00-20.20 (-0.43%)
SBI:1,015.00+2.43 (+0.24%)
Shriram Finance:1,005.10-20.72 (-2.02%)
Bharat Electron:405.00-0.36 (-0.09%)
Kotak Mah. Bank:384.75+1.42 (+0.37%)
Infosys:1,040.90-6.49 (-0.62%)
Bajaj Finance:1,012.80-27.04 (-2.60%)
Adani Enterp.:3,026.40+16.25 (+0.54%)
Sun Pharma.Inds.:1,941.10-12.90 (-0.66%)
JSW Steel:1,240.80-5.98 (-0.48%)
HDFC Bank:742.80-4.48 (-0.60%)
TCS:2,254.30+11.44 (+0.51%)
ICICI Bank:1,432.90-1.72 (-0.12%)
Power Grid Corpn:288.20-1.59 (-0.55%)
Maruti Suzuki:13,442.00+38.87 (+0.29%)
Axis Bank:1,227.30+4.28 (+0.35%)
HCL Technologies:1,271.00+26.26 (+2.11%)
O N G C:248.76-3.61 (-1.43%)
NTPC:347.20-1.39 (-0.40%)
Coal India:427.40+0.34 (+0.08%)
Bharti Airtel:1,898.20-32.83 (-1.70%)
Tech Mahindra:1,559.50+3.73 (+0.24%)
Jio Financial:234.71+1.54 (+0.66%)
Adani Ports:1,768.30-10.14 (-0.57%)
HDFC Life Insur.:555.05+4.08 (+0.74%)
SBI Life Insuran:1,858.60+5.19 (+0.28%)
Max Healthcare:1,080.40-3.79 (-0.35%)
UltraTech Cem.:11,846.00-61.92 (-0.52%)
Bajaj Auto:11,130.00-153.45 (-1.36%)
Bajaj Finserv:1,876.70-12.66 (-0.67%)
Interglobe Aviat:4,985.00-38.68 (-0.77%)
Eternal:280.00-7.09 (-2.47%)
Arihant Plus App

Arihant Plus App

Sun Pharmaceutical Industries Ltd

Sun Pharma.Inds. | 524715

Market Closed
1,941.10
12.90 (-0.66%)
As on 26/07/26, 7:28 AM
Market Cap4,65,734.91 CR
Current Price₹1,941.1
High / Low₹1,966.5 / 1,548
PE Ratio36.73
Book Value₹348.31
Dividend Yield0.91%
ROCE18.72%
ROE12.73%
Face Value₹2.00
Current Vol.15,78,929
Average Vol.---
ISININE044A01036
PB Ratio5.05
Debt to Equity0.04
Net Profit Margin19.78
Operating Margin31.47

Share Price Chart - Sun Pharmaceutical Industries Ltd

+0.00 (+0.00%)6M

Stock Performance

1,9541,945
1,941.1
Previous CloseToday's Open
1,5481,966.5
1,941.1
52W Low52W High
₹1,945Today's Open
₹1,954Previous Close
15,78,929Volume
₹1,54852W Low
₹1,966.552W High

Ratios

No data available

About Company

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No
  • It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids
  • The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals
  • The company has global presence with 40 manufacturing facilities across the world
  • Sun Pharmaceutical Industries Limited was incorporated in 1983
  • The company began operations in Kolkata with just 5 products to treat psychiatry ailments
  • They set up a compact manufacturing facility for tablets/capsules at Vapi

Ethics: Sun Pharmaceutical Industries Ltd is flagged for

paw image

Vegan

No direct or indirect involvement in animal cruelty.

worldwide image

Adequate

The company demonstrates adequate ESG practices with room for improvement.

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI59.45
SMA 201920.62
SMA 501866.69
SMA 1001812.47
SMA 2001764.54
SMA 101945.46
MACD_12_26_Days28.08
EMA10Day1940.84
EMA20Day1920.37
EMA50Day1872.92
MACD_12_26_9_Days-1.20
EMA100Day1827.43
EMA200Day1784.79

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth11.19%
ROE14.85%
EBITDA Margin31.47%

All figures in ₹ Crores

Indicators20262025202420232022
Revenue
58,462.04
52,578.44
48,496.85
43,885.68
38,654.49
Interest
338.91
231.36
238.47
172.00
127.35
Expenses
41,970.82
37,492.28
35,509.85
32,238.89
28,410.73
Financing Profit
19,703.12
17,236.73
14,377.32
12,281.31
11,319.23
Financing Margin %
34%
33%
30%
28%
29%
Other Income
3,211.90
2,150.57
1,390.32
634.52
1,075.47
Depreciation
2,937.85
2,575.39
2,556.64
2,529.43
2,143.74
Profit before tax
15,118.88
13,752.13
11,087.89
9,408.43
4,481.32
Tax %
24%
20%
13%
9%
24%
Net Profit
11,564.52
10,980.10
9,648.44
8,560.84
3,405.82
EPS in Rs
47.80
45.60
39.90
35.30
13.60
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

DealDateTypeQuantityPriceTraded %
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB40004579424 Jun ‘26Purchase1,54,4241,86810.98%
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ40004582824 Jun ‘26Sell1,54,4241,86810.98%
GQG PARTNERS EMERGING MARKETS EQUITY CIT18 Nov ‘25Purchase14,46,4141,763.9101.18%
RELIANCE TRUST INSTITUTIONAL RETIREMENT TRUST SERIES TWELVE18 Nov ‘25Sell14,46,4141,763.9101.18%
GOLDMAN SACHS BANK EUROPE SE - ODI09 Oct ‘25Purchase1,48,2331,631.66.75%
GOLDMAN SACHS (SINGAPORE) PTE - ODI09 Oct ‘25Sell1,48,2331,631.66.75%
THE MTBJ LTD.AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ40004584914 Jul ‘25Purchase3,09,3911,67223.62%
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ40004582814 Jul ‘25Sell3,09,3911,67223.62%
MARSHALL WACE INVESTMENT STRATEGIES MARKET NEUTRAL TOPS FUND25 Jan ‘24Purchase1,27,7121,382.16.83%
MARSHALL WACE INVESTMENT STRATEGIES EUREKA FUND25 Jan ‘24Purchase261,382.10.00%

News

24 Jul 2026 12:00 am

Sun Pharma receives Organon shareholders approval for merger

Sun Pharma receives Organon shareholders approval for merger

Record Date
Corporate Action
Information
Announcement Day
07 Jul 2026
Final Dividend (₹5)
Final dividend of Rs. 5/- (Rupees Five only) per equity share of Re. 1/- (Rupee One only) each is recommended to the shareholders for their approval at the 34th Annual General Meeting (AGM) of the Company. Final dividend, once approved by the shareholders, shall be paid within the prescribed timeline under the Companies Act, 2013
22 May 2026
05 Feb 2026
Interim Dividend (₹11)
An interim dividend of Rs. 11/- (Rupees Eleven only) per equity share of Re. l/- (Rupee One only) each of the Company for the financial year 2025-26 is declared. As intimated on 20 January 2026, the Record Date for entitlement of the interim dividend for the financial year 2025-26 is 05 February 2026. The interim dividend shall be paid on or before 16 February 2026
31 Jan 2026
31 Jul 2025
AGM
AGM
22 May 2025
07 Jul 2025
Final Dividend (₹5.5)
Board recommended final dividend Final dividend of Rs. 5.50/- (Rupees Five and Paise Fifty only) per equity share of Re. l/- (Rupee One only) each is recommended to the shareholders for their approval at the ensuing Annual General Meeting of the Company. Monday, 07 July 2025 is fixed as the Record Date for the purpose of determining the Members eligible to receive the final dividend, which, if approved at the Annual General Meeting, shall be paid on or before Friday, 08 August 2025
22 May 2025
06 Feb 2025
Interim Dividend (₹10.5)
Board approved interim dividend for FY 2024-25
31 Jan 2025
21 Jan 2025
EGM
EGM
10 Dec 2024
05 Aug 2024
AGM
AGM
19 Jun 2024
12 Jul 2024
Final Dividend (₹5)
Board of Directors of the Company was held today i.e. May 22, 2024 Final dividend of Rs. 5/- (Rupees Five only) per equity share of Re. l/- (Rupee One only) each is recommended to the shareholders for their approval at the ensuing Annual General Meeting of the Company. Final dividend, once approved by the shareholders, shall be to be paid within the prescribed timeline under the Companies Act, 2013.
22 May 2024
09 Feb 2024
Interim Dividend (₹8.5)
Meeting of the Board of Directors of the Company ('Board') was held today i.e. January 31, 2024 which commenced at 10:20 a.m. and ended at 1:55 p.m., IST. The Board has, inter-alia, approved the following: Declaration of Interim Dividend for the financial year 2023-24 An interim dividend of Rs. 8.5/- (Rupees Eight and fifty paisa only) per equity share of Re. l/- (Rupee one only) each of the Company for the financial year 2023-24 is declared. As intimated on January 15, 2024, the Record Date for entitlement of interim dividend for the financial year 2023-24 is February 09, 2024. The interim dividend shall be paid on or before February 23, 2024.
31 Jan 2024
28 Aug 2023
AGM
AGM
07 Jul 2023

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
1,941
4,65,711
37
6
30
0
19.78%
7,247
1,92,376
73
11
62
0
24.32%
4,960
1,88,655
86
22
57
1
11.09%
1,411
1,13,979
32
3
24
0
9.92%
1,109
1,10,613
20
4
16
0
9.82%
2,369
1,08,339
19
5
15
0
19.16%
2,505
1,03,472
51
6
36
0
13.57%
1,153
96,205
30
3
18
0
12.34%
1,532
88,950
25
2
17
0
10.98%
1,602
86,564
79
16
55
1
13.06%
Showing 10 of 133 Results

Frequently Asked Questions

What is Share Price of Sun Pharmaceutical Industries Ltd?

The current share price of Sun Pharmaceutical Industries Ltd (Sun Pharma.Inds.) is ₹1941.10. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Sun Pharmaceutical Industries Ltd?

The Price-to-Earnings (P/E) ratio of Sun Pharmaceutical Industries Ltd is 1941.10. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Sun Pharmaceutical Industries Ltd?

Sun Pharmaceutical Industries Ltd has a 52-week high of ₹1966.50 and a 52-week low of ₹1548.00. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Sun Pharmaceutical Industries Ltd?

Sun Pharmaceutical Industries Ltd offers a dividend yield of 0.82%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Sun Pharmaceutical Industries Ltd?

The Earnings Per Share (EPS) of Sun Pharmaceutical Industries Ltd is ₹51.80. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Sun Pharmaceutical Industries Ltd?

Sun Pharmaceutical Industries Ltd has a Return on Equity (ROE) of 12.73%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2